Laser Therapy + 7-940 for Vaginal Atrophy
(ASSIST-VLA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Vaginal atrophy patients receiving vaginal laser therapy will be treated with daily 7-0940® following a laser session to evaluate the safety and efficacy of the product as an adjunct treatment. Clinical outcomes will be assessed using validated investigator- and patient-reported measures, with safety and symptom progression monitored throughout the study.
Are You a Good Fit for This Trial?
This trial is for individuals with diagnosed vaginal atrophy who have access to a smart device and email, and have completed laser therapy sessions. It's not specified who can't join the trial.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive vaginal laser therapy followed by daily 7-0940® treatment to evaluate safety and efficacy
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- 7-940
Trial Overview
The study tests the safety and effectiveness of daily treatment with 7-0940® after vaginal laser therapy in patients with vaginal atrophy, using both investigator and patient assessments.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stratpharma AG
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.